Citadel Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,204,700
| Closed | -$120M | – | 10286 |
|
|
2019
Q3 | $120M | Buy |
1,204,700
+876,600
| +267% | +$83.3M | 0.06% | 324 |
|
|
2019
Q2 | $30.3M | Sell |
328,100
-1,432,100
| -81% | -$136M | 0.01% | 1061 |
|
|
2019
Q1 | $166M | Buy |
1,760,200
+463,000
| +36% | +$40.5M | 0.08% | 191 |
|
|
2018
Q4 | $83.1M | Buy |
1,297,200
+123,600
| +11% | +$9.12M | 0.05% | 392 |
|
|
2018
Q3 | $105M | Sell |
1,173,600
-930,600
| -44% | -$82.2M | 0.05% | 396 |
|
|
2018
Q2 | $167M | Buy |
2,104,200
+455,800
| +28% | +$37.8M | 0.08% | 202 |
|
|
2018
Q1 | $147M | Sell |
1,648,400
-847,600
| -34% | -$81.4M | 0.08% | 200 |
|
|
2017
Q4 | $260M | Buy |
2,496,000
+1,785,300
| +251% | +$201M | 0.16% | 96 |
|
|
2017
Q3 | $104M | Buy |
710,700
+37,300
| +6% | +$5.08M | 0.08% | 245 |
|
|
2017
Q2 | $87.5M | Buy |
673,400
+181,300
| +37% | +$22.2M | 0.07% | 276 |
|
|
2017
Q1 | $61.2M | Sell |
492,100
-169,700
| -26% | -$20.3M | 0.06% | 356 |
|
|
2016
Q4 | $76.6M | Buy |
661,800
+130,200
| +24% | +$14.5M | 0.08% | 233 |
|
|
2016
Q3 | $55.6M | Sell |
531,600
-41,000
| -7% | -$4.44M | 0.06% | 341 |
|
|
2016
Q2 | $56.5M | Buy |
572,600
+169,300
| +42% | +$17.5M | 0.06% | 296 |
|
|
2016
Q1 | $40.4M | Sell |
403,300
-90,500
| -18% | -$9.32M | 0.05% | 381 |
|
|
2015
Q4 | $59.1M | Sell |
493,800
-92,000
| -16% | -$10.6M | 0.06% | 328 |
|
|
2015
Q3 | $63.4M | Buy |
585,800
+74,200
| +15% | +$9.21M | 0.06% | 335 |
|
|
2015
Q2 | $59.2M | Sell |
511,600
-232,600
| -31% | -$26.6M | 0.05% | 423 |
|
|
2015
Q1 | $85.8M | Sell |
744,200
-54,600
| -7% | -$6.52M | 0.08% | 270 |
|
|
2014
Q4 | $89.4M | Buy |
798,800
+112,500
| +16% | +$11.9M | 0.09% | 231 |
|
|
2014
Q3 | $65M | Buy |
686,300
+191,500
| +39% | +$17.3M | 0.07% | 317 |
|
|
2014
Q2 | $42.5M | Sell |
494,800
-584,600
| -54% | -$44.5M | 0.05% | 456 |
|
|
2014
Q1 | $75.3M | Sell |
1,079,400
-17,400
| -2% | -$1.38M | 0.09% | 237 |
|
|
2013
Q4 | $92.7M | Buy |
1,096,800
+240,600
| +28% | +$19M | 0.12% | 167 |
|
|
2013
Q3 | $65.9M | Buy |
856,200
+62,600
| +8% | +$4.39M | 0.1% | 212 |
|
|
2013
Q2 | $46.4M | Buy |
+793,600
| New | +$47.8M | 0.08% | 281 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Citadel Advisors's CELG Position: Q4 2019 in Review
Citadel Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,854,309 shares — an estimated $681M sold.
Citadel Advisors first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $681M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Citadel Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Citadel Advisors sold 6,854,309 Celgene Corp shares in Q4 2019, an estimated $681M.
- Citadel Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
- Citadel Advisors's Celgene Corp position peaked at $681M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.